SCHEMBL8367296

SCHEMBL8367296

O=C1C=C(NCCN(CCO)CCO)C(=O)c2ncc(-c3ccco3)nc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S100A4 P26447 1/20 0.39
MAPT P10636 3/20 0.33
CDC25A P30304 2/20 0.33
CDC25B P30305 2/20 0.33
CDC25C P30307 2/20 0.33
ATR Q13535 2/20 0.33
BLM P54132 2/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 1/20 0.33
RAD52 P43351 1/20 0.33
RAB9A P51151 1/20 0.33
UBE2I P63279 1/20 0.33
CACNA1B Q00975 1/20 0.33
APBA1 Q02410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8369468 0.88 MALT1 (0.45) S100A4CDC25ACDC25BCDC25CATR
SCHEMBL8370510 0.82 S100A4 (0.46) S100A4MAPTBLMCASP1CASP7
SCHEMBL8368658 0.76 S100A4 (0.44) S100A4MAPTCDC25ACDC25BCDC25C
SCHEMBL8371649 0.76 S100A4 (0.48) S100A4MAPTCDC25ACDC25BCDC25C
SCHEMBL8367303 0.72 CDK4 (0.45) MAPTATRBLMTP53SMN1; SMN2
SCHEMBL8368655 0.71 MALT1 (0.41) S100A4MAPTCDC25ACDC25BCDC25C
SCHEMBL8367274 0.70 S100A4 (0.56) S100A4MAPTCDC25ACDC25BCDC25C
SCHEMBL8369500 0.68 ALDH1A1 (0.44) MAPTATRBLMCASP1CASP7
SCHEMBL8368881 0.65 S100A4 (0.49) S100A4MAPTBLMCASP1CASP7
SCHEMBL8370523 0.64 S100A4 (0.51) S100A4MAPTBLMCASP1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999052365-A1 ANTICANCER AGENTS ELI LILLY AND COMPANY (US) 1999-10-21 WO disclosed